Minor neurological signs and behavioural function at age 2 years in neonatal hypoxic ischaemic encephalopathy (HIE)
Edmonds, C., Helps, A., Hart, D., Zatorska, A. M., Gupta, N., Cianfaglione, R. and Vollmer, B. 2020. Minor neurological signs and behavioural function at age 2 years in neonatal hypoxic ischaemic encephalopathy (HIE). European Journal of Paediatric Neurology. 27, pp. 78-85. https://doi.org/10.1016/j.ejpn.2020.04.003
|Authors||Edmonds, C., Helps, A., Hart, D., Zatorska, A. M., Gupta, N., Cianfaglione, R. and Vollmer, B.|
Background: Neurodevelopmental follow-up in Neonatal Hypoxic Ischaemic Encephalopathy (HIE) typically focusses on major neuromotor (cerebral palsy, CP) and severe cognitive impairment. Outcomes in those without major neuromotor impairment are less well explored.
Methods: Clinical routine outcome data from children admitted to a tertiary centre with neonatal HIE for hypothermia treatment between 05/08/09 - 30/05/2016. Children were assessed for neuromotor status – particularly minor neurological signs (MNS), with Bayley Scales of Infant and Toddler Development III (Bayley III) or Ages and Stages Questionnaire-3 (ASQ), Child Behavior Checklist 1.5-5 (CBCL), Quantitative Checklist for Autism in Toddlers (Q-CHAT).
Results: Of 107 children, 75.5% had normal neurology, 12.1% CP, 12.1% MNS. Children with CP were excluded from analyses. For those without CP, Bayley-III scores were in the average range for the majority; mild cognitive delay observed in 5%, 4.2% language, 1.3% motor development; severe delay in 1.3% for cognitive, 4.2% for language. More than in the normative population scored in clinical ranges for CBCL externalising, sleep, and other problems. No significant difference was seen for Q-CHAT. Children with MNS were significantly more likely to have impaired Bayley-III scores, parent-reported internalising, sleep, and other problems.
Conclusions: In this clinical cohort, the majority of children had favourable outcome at 2 years. However, children with MNS were at risk for cognitive and behavioural difficulties and will benefit from enhanced clinical follow-up and support.
|Journal||European Journal of Paediatric Neurology|
|Journal citation||27, pp. 78-85|
|Publisher||Elsevier for European Paediatric Neurology Society|
|Accepted author manuscript|
File Access Level
|Digital Object Identifier (DOI)||https://doi.org/10.1016/j.ejpn.2020.04.003|
|Web address (URL)||https://doi.org/10.1016/j.ejpn.2020.04.003|
|Online||11 Apr 2020|
|Publication process dates|
|Accepted||07 Apr 2020|
|Deposited||16 Apr 2020|
|Copyright holder||© 2020 Elsevier|
Accepted author manuscript
3views this month
0downloads this month